7253-52-3

Usage

Uses

Used in Pharmaceutical Applications:
(5Z)-5-(4-methoxybenzylidene)-2-thioxoimidazolidin-4-one is used as a pharmaceutical compound for its potential therapeutic properties. (5Z)-5-(4-methoxybenzylidene)-2-thioxoimidazolidin-4-one's unique structure and reactivity may allow it to interact with biological targets, making it a promising candidate for the development of new drugs.
Used in Agrochemical Applications:
In the agrochemical industry, (5Z)-5-(4-methoxybenzylidene)-2-thioxoimidazolidin-4-one is used as a chemical intermediate for the synthesis of various agrochemical products. Its structural features may contribute to the development of new pesticides, herbicides, or other agricultural chemicals that can improve crop protection and yield.
Used in Material Science Applications:
(5Z)-5-(4-methoxybenzylidene)-2-thioxoimidazolidin-4-one is used as a building block in the development of novel materials in material science. Its heterocyclic structure and potential reactivity may enable the creation of new materials with specific properties, such as improved mechanical strength, thermal stability, or chemical resistance, for various industrial applications.

Upstream product

• 503-87-7 2-thiohydantoin 
• 123-11-5 4-methoxy-benzaldehyde 
• 109-77-3 malononitrile 

Downstream Products

• 14827-13-5 5-(4-methoxy-benzylidene)-2-methylsulfanyl-3,5-dihydro-imidazol-4-one 
• 911371-83-0 5-[1-(4-Methoxy-phenyl)-meth-(Z)-ylidene]-2-(2-oxo-propylsulfanyl)-3,5-dihydro-imidazol-4-one 
• 911371-74-9 2-{4-[1-(4-Methoxy-phenyl)-meth-(Z)-ylidene]-5-oxo-4,5-dihydro-1H-imidazol-2-ylsulfanyl}-3-oxo-butyric acid ethyl ester 
• 14748-39-1 5-(4-methoxy-benzylidene)-3-methyl-2-methylsulfanyl-3,5-dihydro-imidazol-4-one 
• 5349-42-8 5-(4-methoxybenzylidene)imidazolidine-2,4-dione 
• 129228-60-0 6-[1-(4-Methoxy-phenyl)-meth-(Z)-ylidene]-2,3-dihydro-6H-imidazo[2,1-b]thiazol-5-one 

Relevant academic research and scientific papers

in Water : Organocatalyzed Diastereoselective Multicomponent Reactions toward 2-Azapyrrolizidine Alkaloid Scaffolds

Synthesis of the 2-aza analogues of pyrrolizidine and spirooxindole-2-azapyrrolizidine hybrid, a spiro-tetracyclic scaffold possessing multiple contiguous stereocenters, by an exclusive regio-, chemo-, and diastereoselective multicomponent reaction in water is reported. This logical and didactical tactic has integrated the principles of an ideal organic synthesis, privileged substructure-based diversity-oriented synthesis, and biology-oriented synthesis to access hybrid heterocyclic scaffolds.

A heterocyclic compound and use thereof

The invention relates to a heterocyclic compound as shown in a general formula I which is described in the specification and application of the heterocyclic compound as a plant disease resistance activator. In the general formula I, R1 is selected from the group consisting of hydrogen, a C1-C6 alkyl group and a C3-C6 cycloalkyl group, R2 is selected from the group consisting of hydrogen, a C1-C6 alkyl group, a substituted or non-substituted C1-C14 aryl group and a five-membered or six-membered heterocycle containing nitrogen, oxygen and sulfur, and n is a positive integer in a range of 2 to 4. The compound provided by the invention inhibits pathogens through inducing a plant to generate disease resistance against pathogens instead of directly killing or inhibiting pathogens. The compound provided by the invention has the advantages of systematicness, persistence, broad spectrum activity, security, etc., enables the usage amount of highly toxic pesticides to be reduced and is friendly to the environment; so the compound has great industrial and commercial prospects and a great market value.

Design and Synthesis of Novel Phenylpiperazine Derivatives as Potential Anticonvulsant Agents

Eighteen new 5-benzylidene-3-(4-arylpiperazin-1-ylmethyl)-2-thioxo-imidazolidin-4-ones were designed as hybrid structures from previously reported anticonvulsant compounds, synthesized and tested for anticonvulsant activity. Initial anticonvulsant screeni

Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Part 1

The series of glycine derivatives of diphenyl or (un)substituted arylidene imidazolones was designed and obtained as potential ligands of the glycine binding site of NMDA receptors. The compounds were evaluated in vitro for their affinity to the glycine b